Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Tembhare

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Leukemia & Lymphoma|January 15, 2013
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical studyBenjamin M Cherry, Neha Korde, Mary Kwok, et al.
Blood Cancer Journal|January 8, 2026
Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple MyelomaSumeet Mirgh, Arti Goel, Sachin Punatar, et al.
Cytotherapy|February 4, 2025
A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilizationAnant Gokarn, Laxma Reddy, Sumathi Hiregoudar, et al.
Ejhaem|December 12, 2025
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in IndiaGeorge John, Sumeet Mirgh, Sachin Punatar, et al.
Indian Journal of Pathology & Microbiology|March 24, 2018
Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiencesSushil Modkharkar, Pooja Navale, Pratibha Kadam Amare, et al.
Blood Cancer Journal|May 7, 2020
NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological MalignanciesNikhil Patkar, Prasanna Bhanshe, Sweta Rajpal, et al.
Leukemia|February 9, 2021
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh, et al.
Leukemia & Lymphoma|March 22, 2016
Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistanceNikhil Patkar, Kiran Ghodke, Swapnali Joshi, et al.
Oncotarget|December 20, 2018
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Oncotarget|February 8, 2019
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Leukemia & Lymphoma|January 15, 2013
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical studyBenjamin M Cherry, Neha Korde, Mary Kwok, et al.
Blood Cancer Journal|January 8, 2026
Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple MyelomaSumeet Mirgh, Arti Goel, Sachin Punatar, et al.
Cytotherapy|February 4, 2025
A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilizationAnant Gokarn, Laxma Reddy, Sumathi Hiregoudar, et al.
Ejhaem|December 12, 2025
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in IndiaGeorge John, Sumeet Mirgh, Sachin Punatar, et al.
Indian Journal of Pathology & Microbiology|March 24, 2018
Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiencesSushil Modkharkar, Pooja Navale, Pratibha Kadam Amare, et al.
Blood Cancer Journal|May 7, 2020
NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological MalignanciesNikhil Patkar, Prasanna Bhanshe, Sweta Rajpal, et al.
Leukemia|February 9, 2021
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh, et al.
Leukemia & Lymphoma|March 22, 2016
Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistanceNikhil Patkar, Kiran Ghodke, Swapnali Joshi, et al.
Oncotarget|December 20, 2018
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Oncotarget|February 8, 2019
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Pageof 9